Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Catalent Inc (NY: CTLT )

110.46 USD -0.53 (-0.48%)
Streaming Delayed Price Updated: 1:56 PM EDT, Apr 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 403,527
Open 111.61
Bid (Size) 110.43 (1)
Ask (Size) 110.49 (3)
Prev. Close 110.99
Today's Range 109.86 - 111.61
52wk Range 54.21 - 127.68
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Moderna and Catalent Announce Long-Term Strategic Collaboration for Dedicated Vial Filling of Moderna’s COVID-19 Vaccine and Clinical Portfolio
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery... 
From Business Wire News Releases
Moderna and Catalent Announce Long-Term Strategic Collaboration for Dedicated Vial Filling of Moderna’s COVID-19 Vaccine and Clinical Portfolio
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery... 
From Business Wire News Releases

Performance

YTD
+6.49%
+6.49%
1 Month
+6.70%
+6.70%
3 Month
-4.15%
-4.15%
6 Month
+19.80%
+19.80%
1 Year
+100.04%
+100.04%

More News

Read More
Cybin Signs Drug Development Agreement with Catalent for its Fast-Dissolve Formulation of Novel, Deuterated Tryptamine (CYB003)
From Business Wire News Releases
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Enters Strategic Drug Development Agreement with Catalent Inc. (NYSE: CTLT)
From InvestorBrandNetwork
Catalent Now #352 Largest Company, Surpassing Darden Restaurants
Tags Stocks
From Market News Video
Biden advances timeline for COVID vaccine eligibility as experts warn Americans, ‘the war is not yet won’
Tags MRNA DVAX JNJ
From MarketWatch
Catalent To Boost Output Of Finished Vials For Moderna's COVID-19 Shot: WSJ
Tags General COVID/19 Vaccine Government
From Benzinga
Analysts Forecast 11% Upside For The Holdings of XLV
Tags ETFs
From ETF Channel
A Peek Into The Markets: US Stock Futures Gain Ahead Of Economic Data, Fed Speakers
Tags Markets WGO WOR
From Benzinga
J&J COVID-19 Vaccine To Get Supply Boost As Manufacturing Partner Secures Key FDA Clearance
Tags News Benzinga Covid/19 vaccines
From Benzinga
IQVIA Holdings Takes Over #33 Spot From Catalent
Tags ETFs
From ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.